Practice Profile | Joseph T. Hill, JD

• Patent and Trademark Prosecution
• Intellectual Property Transactions and Licensing

Registered US Patent Attorney | USPTO Reg. No. 81,439

Oregon State Bar | OSB #190,211 

 Juris Doctor (w/ Intellectual Property Certificate)

Lewis & Clark Law School, Portland, OR – May 2018

Bachelor of Science, Microbiology 

Brigham Young University, Provo, UT – August 2005

• “Methods of Gene Therapy”: U.S. Prov. Patent App. No. 62/664,930 (filed Apr. 30, 2018) and U.S. Provisional Patent App. No. 62/664,932 (filed Apr. 30, 2018) — (I wrote the specifications only which were used to support PCT/US19/29890 (filed 4/30/2019); the final PCT specification and claims were drafted by outside counsel.)
• “Multi-workstation Computer Display Support Structure for reducing EHR-Related Medical Errors Occurring during Inter-professional Patient Rounds”: U.S. Prov. Patent App. No. 62/882,366 (filed Aug. 2, 2019) and U.S. Patent App. No. 16/941,132 (filed July 28, 2020)
• “Molecular Scaffolds for Regenerative Medicine”: PCT/US19/43798 (filed July 26, 2019) and PCT/US20/15952 (filed Jan. 30, 2020)
• “Compositions, Systems, and Methods for Measuring Protein Secretion at a Single-Cell Level”: U.S. Prov. Patent App. No. 62/947,290 (filed Dec. 12, 2019); PCT/US20/64967 (filed Dec. 14, 2020)
• “Ultrasound-Based Intravascular Placement Guide Structure”: U.S. Prov. Patent App. No. 63/028,362 (filed May. 21, 2020); PCT/US21/31188 (filed May 6, 2021)
• “Molecular barcodes and related methods and systems”: U.S. Prov. Patent App. No. 63/156,858 (filed Mar. 4, 2021); PCT/US2022/019045 (filed Mar. 4, 2022).

Oregon Health & Science University | Technical Specialist

OHSU Technology Transfer & Business Development Office, Portland OR, April 2019 – March 2023 

• Drafted patent applications on biotech, medical device, and mechanical arts subject matter
• Advised on strategy and prosecution of assigned IP portfolio
• Developed and maintained strong working relationships with principal investigators and other inventors
• Oversaw outside counsel work product
• Advised OHSU workgroups on background patent law issues
• Mentored OHSU Technology Transfer interns on patent prosecution and claim drafting.

Stoel Rives, LLP | Patent Prosecution Secondment

Stoel Rives, LLP, Portland, OR April 2019 – January 2020

• Completed specification and claim drafting exercises under supervision of mentoring attorney.
• Drafted objective infringement analysis memoranda. 

Oregon Health & Science University | Agreements Officer: 

OHSU Technology Transfer & Business Development Office, Portland OR, January 2017 – April 2019

• Reviewed, drafted, and negotiated material transfer, non-disclosure, sponsored research, collaboration, equipment loan, SBIR/STIR sub-award, data-use, business-associate and material license agreements.
• Ensure compliance with IRC 501(c)3, HIPAA, U.S. Export Control, Bayh-Dole, Oregon Public Records, and Oregon Genetic Privacy law.

Oregon Health & Science University | Patent Extern: 

OHSU Technology Transfer & Business Development Office, Portland OR, August 2017 – May 2018

• Drafted provisional applications for CRISPR, gene-therapy, and cancer early-detection technologies.
• Conducted inventor interviews.
• Researched and drafted legal memoranda on background patent law issues including patent eligible subject matter, creation of prior art, inventorship/nonjoinder, and patent landscape analysis.

Jackson White, P.C. | Law Clerk: 

Jackson White, P.C. Mesa AZ (Remote), April 2016 – August 2016

• Researched and drafted client letters, legal memoranda, and trial briefs related to:
  • American Disabilities Act interactive process
  • Employee Retirement Income Security Act interference
  • Private sector whistleblower retaliation, and
  • Family Medical Leave Act interference.

Kaiser Permanente | Supervisor and Technical Specialist of Molecular Diagnostics: 

Kaiser Permanente, Portland OR, August 2011 – July 2016  

• Supervised daily operations of molecular diagnostics laboratories.
• Ensured College of American Pathology and Clinical Laboratory Improvement Amendments’88 compliance.
• Selected and validated molecular diagnostic test methodologies for both lab developed and in vitro diagnostic (IVD) testing.
• Established and maintained quality control and proficiency testing programs.

PeaceHealth Laboratories | Supervisor of Molecular Diagnostics 

PeaceHealth Laboratories, Eugene, OR, July 2008 – July 2011

• Supervised daily operations of molecular diagnostics laboratories.
• Ensured College of American Pathology and Clinical Laboratory Improvement Amendments’88 compliance.
• Selected and validated molecular diagnostic test methodologies for both lab developed and in vitro diagnostic (IVD) testing.
• Established and maintained quality control and proficiency testing programs.

United States Department of Defense | Assistant Scientist - Microbiologist

US Dept. of Defense, Dugway Proving Grounds, UT, September 2007 - July 2008

• Conducted antigen production and quality control using culture, real-time PCR, and HPLC for the Critical Reagent Program of the DoD.

ARUP Laboratories | Laboratory Techologist II

ARUP Laboratories, Salt Lake City, UT, August 2003 – September 2007

• ASCP(MP) board certification
• Responsible for performing clinical diagnostics testing in the Molecular Sequencing and Molecular Hepatitis/Retrovirus laboratories.

• Hill JT, Tran KT, Barton KL, Labreche MJ, Sharp SE. (2014) Evaluation of the Nanosphere Verigene BC-GN Assay for Direct Identification of Gram-Negative Bacilli and Antibiotic Resistance Markers from Positive Blood Cultures and Potential Impact for More-Rapid Antibiotic Interventions J. Clin. Micro. Aug 2014.
• Hill JT, Tran KT, Barton KL, Labreche MJ, Sharp SE. (2014) Evaluation of the Nanosphere-Verigene GN-BC for the Identification of Gram Negative Bacilli and detection of Antibiotic Resistance Mechanisms Directly from Positive Blood Cultures. Poster presented at: American Society for Microbiology General Meeting (2014)
• Hill JT, Sharp SE. (2012) Protocol for Direct Detection of Mycoplasma pneumoniae from Sputum without inhibition of the Focus Diagnostics M. pneumoniae Analyte Specific Reagent (ASR) PCR chemistry. Poster presented at: Association for Molecular Pathology Annual Meeting (2012)
• Quigley DI, Elbaz M, Hill JT, McDonald J.E. (2012) HPV Testing of Anal Specimens: Prevalence and Correlation with Cytology and Histology Poster presented at: Association for Molecular Pathology Annual Meeting (2012)
• Liao RS, McCarthy S, Starr S, Ash V, Hill JT (2011) Evaluation of the Gen-Probe APTIMA Trichomonas vaginalis Assay with the APTIMA Combo 2 Assay for detection of Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) Poster presented at: Association for Molecular Pathology Annual Meeting (2011)
• Liao RS, Landt O, Hill JT. (2011) Comparison of a Lab Developed RT-PCR and the CDC RT-PCR protocol with Rapid Immunodiagnostic Testing during the 2009 H1N1 Influenza A Pandemic DiagnMicrInfec Dis. Jun 2011.
• Appelgate D, Liao RS, Hill JT. (2010) Evaluation of Rapid Diagnostic Tests and Multiplex PCR for Pandemic Influenza A. Poster presented at: 48th Annual Meeting of the Infectious Disease Society of America; 2010 Oct 21-24; Vancouver, BC.